Barclays Plc and HSBC Holdings Plc are pushing for a shift in investment strategy toward inflation-linked bonds. This recommendation comes after Fed Chair Kevin Warsh refused to clarify how the central bank will manage rising inflation. Investors are now worried the Federal Reserve could be slow to act on accelerating price increases.
Long-term U.S. yields recently reached their highest level in nearly two decades, fueled by Warsh's lack of specific guidance. Meanwhile, breakeven rates, which reflect market expectations for inflation, hit a 12-month low. Jon Hill, Barclays' U.S. inflation market strategy head, said the lack of clarity from the Fed could lead the market to price in more inflation risk. This, he explained, might widen breakeven spreads and lift inflation-linked bonds ahead of traditional ones.
Rethinking Bonds as Inflation Protection
Inflation-linked bonds offer investors a safeguard against rising prices by adjusting their returns based on current inflation rates. These instruments are now performing better than standard sovereign bonds, even though the gap remains narrow. While an index tracking inflation-linked debt rose 0.3% this year, conventional sovereigns suffered a 0.7% drop in the same time frame. The real yield, or the part not tied to inflation, for 30-year U.S. Treasury Inflation Protected Securities (TIPS) stands at 2.93%, down slightly from its peak of 3.04% on Friday.
HSBC's Dhiraj Narula echoed the need to focus on long-term U.S. bonds that offer inflation protection. His concerns are centered on the Fed's long-term commitment to containing price increases. He emphasized the growing uncertainty around the central bank’s ability to control inflation, which has led to a renewed interest in these types of assets.
Other investment firms are also adjusting their portfolios. Kevin Kidney, with True Potential Investments LLC, boosted his firm’s allocation to inflation-linked sovereign bonds to around 20% of fixed-income holdings. He believes central banks, including the Fed, are more accepting of higher inflation than they publicly admit. According to Kidney, these institutions may prioritize economic growth over strict inflation control, even if their stated goals suggest otherwise.